Bleeding Disorders

MD IQ

News

Canada approves Jivi for hemophilia A

Health Canada has approved Jivi® (antihemophilic factor [recombinant, B-domain deleted, PEGylated]) for use in patients with hemophilia A. Jivi (...

News

CHMP recommends change for eptacog alfa

The European Medicine’s Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended a change to the terms of the marketing...

Pages